Growth Metrics

Quest Diagnostics (DGX) Asset Writedowns and Impairment (2016 - 2019)

Quest Diagnostics has reported Asset Writedowns and Impairment over the past 11 years, most recently at $2.0 million for Q4 2019.

  • Quarterly Asset Writedowns and Impairment fell 50.0% to $2.0 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $11.0 million through Dec 2019, up 83.33% year-over-year, with the annual reading at $5.0 million for FY2024, 400.0% up from the prior year.
  • Asset Writedowns and Impairment was $2.0 million for Q4 2019 at Quest Diagnostics, down from $4.0 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $86.0 million in Q1 2016 and troughed at -$235.0 million in Q4 2016.
  • The 5-year median for Asset Writedowns and Impairment is $3.5 million (2017), against an average of $16.4 million.
  • Biggest five-year swings in Asset Writedowns and Impairment: crashed 461.54% in 2016 and later skyrocketed 133.33% in 2019.
  • Tracing DGX's Asset Writedowns and Impairment over 5 years: stood at $65.0 million in 2015, then crashed by 461.54% to -$235.0 million in 2016, then skyrocketed by 101.28% to $3.0 million in 2017, then surged by 33.33% to $4.0 million in 2018, then tumbled by 50.0% to $2.0 million in 2019.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $2.0 million, $4.0 million, and $1.0 million for Q4 2019, Q3 2019, and Q2 2019 respectively.